country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

Cat. No.: HY-164152A

Copy Link Print Information

ADC Control Human IgG1-Deruxtecan (DAR 8)

Name: ADC Control Human IgG1-Deruxtecan (DAR 8)
Brand: MedChemExpress
SKU: HY-164152A
Price: 980.00 USD
Availability: InStock
Rating: 5 (1 reviews)

1 Cited Publications

Customer Review

Based on 1 publication(s) in Google Scholar

ADC Control Human IgG1-Deruxtecan (DAR 8) is a humanized monoclonal antibody that is an isotype control of ADC human IgG1-Deruxtecan and can inhibit DNA topoisomerase I. The antibody portion is Human IgG1 kappa, Isotype Control (HY-P99001), and the drug-linker conjugate for ADC is Deruxtecan (HY-13631E).

For research use only. We do not sell to patients.

Purity: 99.32%
Molecular Weight:153621.00

Storage:

-80°C, protect from light

ADC Control Human IgG1-Deruxtecan (DAR 8) Chemical Structure

Size

Price

Stock

Quantity

Amount: USD 0.00

* Please select Quantity before adding items.

Top Publications Citing

Use of MCE Products

One-stop CDMO Service

One-Stop Platform：From Independent R&D to Pilot-Scale Production

Biological Activity
- Description
- In Vitro
Chemical Information
Publications (1)
Purity & Documentation
References
Calculators
Help & FAQs
Classifications
Bioz

Biological Activity

Description

All Topoisomerase Isoforms :

In Vitro

ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker.

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Chemical Information

Appearance Liquid
Molecular Weight 153621.00
Color Colorless to light yellow
SMILES

[ADC Control Human IgG1-Deruxtecan (DAR 8)]
Shipping

Shipping with dry ice.
Storage

-80°C, protect from light

Publications (1)

All

Sort by:

Journal Impact Factor

Mol Carcinog

Targeting TROP2 and Exploiting AUNIP as a Determinant of ADC Cytotoxicity and Chemosensitivity in HNSCC and ESCA Cancers. [Abstract]

2026 May 7. PMID: 42096614

Purity & Documentation

Select Batch:

Purity: 99.98%

Assay: 99.98%

ee.: 99.98%

Data Sheet (263 KB)
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
COA (2659 KB)
Elemental Analysis Report (2659 KB)
HNMR (2659 KB)
CNMR (2659 KB)
RP-HPLC (2659 KB)
NP-HPLC (2659 KB)
MS (2659 KB)
LCMS (2659 KB)
IR (2659 KB)
GC (2659 KB)
OR (2659 KB)
SDS-PAGE (2659 KB)
SEC-HPLC (2659 KB)
Other Report (2659 KB)
Handling Instructions (2659 KB)

References

[1]. Matilde Bocci, et al. In vivo activation of FAP-cleavable small molecule-drug conjugates for the targeted delivery of camptothecins and tubulin poisons to the tumor microenvironment. J Control Release. 2024 Mar:367:779-790. [Content Brief]

Calculators

Molarity Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Concentration Concentration

Volume Volume

Molecular Weight Molecular Weight

Dilution Calculator

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

Concentration _(start) Concentration _(start)

Volume _(start) Volume _(start)

Concentration _(final) Concentration _(final)

Volume _(final) Volume _(final)

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Bioz

Keywords

ADC Control Human IgG1-Deruxtecan (DAR 8)

1 Cited Publications

100 mg Get Quote

Subscribe to the

MedChemExpress

Newsletter

MOQ

Minimum order quantity

100 mg

Get Quote In-stock

Other size

Get Quote

Amount: USD 0.00

Biological Activity
- Description
- In Vitro
Chemical Information
Publications (1)
Purity & Documentation
References

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent:

Product Name:
CAS No.:
Species:
Purity:
Quantity:

ADC Control Human IgG1-Deruxtecan (DAR 8)

Trastuzumab deruxtecan (solution)

Trastuzumab deruxtecan

Ifinatamab deruxtecan

Human IgG1 kappa, Isotype Control

ADC Control Human IgG1-vcMMAE (DAR4, solution)

ADC Control Human IgG1-Deruxtecan (DAR 4)

Sacituzumab govitecan

DXd

Trastuzumab

Sacituzumab govitecan (solution)

Mirvetuximab soravtansine (solution)

Patritumab deruxtecan

Publications Citing Use of MedChemExpress (MCE) ADC Control Human IgG1-Deruxtecan (DAR 8)

All Topoisomerase Isoforms

Biological Activity

Chemical Information

Publications (1)

Purity & Documentation

References

Calculators

Help & FAQs

Bioz

ADC Control Human IgG1-Deruxtecan (DAR 8)

Trastuzumab deruxtecan (solution)

Trastuzumab deruxtecan

Ifinatamab deruxtecan

Human IgG1 kappa, Isotype Control

ADC Control Human IgG1-vcMMAE (DAR4, solution)

ADC Control Human IgG1-Deruxtecan (DAR 4)

Sacituzumab govitecan

DXd

Trastuzumab

Sacituzumab govitecan (solution)

Mirvetuximab soravtansine (solution)

Patritumab deruxtecan

Publications Citing Use of MedChemExpress (MCE) ADC Control Human IgG1-Deruxtecan (DAR 8)

All Topoisomerase Isoforms

Biological Activity

Chemical Information

Publications (1)

Purity & Documentation

References

Calculators

Help & FAQs

ADC Control Human IgG1-Deruxtecan (DAR 8) Related Classifications

HY-164152A Related Classifications

Bioz